Model-based glycaemic control: methodology and initial results from neonatal intensive care

Abstract Very/extremely premature infants often experience glycaemic dysregulation, resulting in abnormally elevated (hyperglycaemia) or low (hypoglycaemia) blood glucose (BG) concentrations, due to prematurity, stress, and illness. STAR-GRYPHON is a computerised protocol that utilises a model-based insulin sensitivity parameter to directly tailor therapy for individual patients and their changing conditions, unlike other common insulin protocols in this cohort. From January 2013 to January 2015, 13 patients totalling 16 hyperglycaemic control episodes received insulin under STAR-GRYPHON. A significant improvement in control was achieved in comparison to a retrospective cohort, with a 26% absolute improvement in BG within the targeted range and no hypoglycaemia. This improvement was obtained predominantly due to the reduction of hyperglycaemia (%BG>10.0 mmol/l: 5.6 vs. 17.7%, p<0.001), and lowering of the median per-patient BG [6.9 (6.1–7.9) vs. 7.8 (6.6–9.1) mmol/l, p<0.001, Mann-Witney U test]. While cohort-wide control results show good control overall, there is high intra-patient variability in BG behaviour, resulting in overly conservative treatments for some patients. Patient insulin sensitivity differs between and within patients over time, with some patients having stable insulin sensitivity, while others change rapidly. These results demonstrate the trade-off between safety and performance in a highly variable and fragile cohort.

[1]  W. Sexson.  Incidence of neonatal hypoglycemia: a matter of definition. , 1984, The Journal of pediatrics.

[2]  Insulin pump therapy in the very low birth weight infant. , 1986, Pediatrics.

[3]  T. Cole,et al.  Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. , 1988, BMJ.

[4]  G. Benda,et al.  Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. , 1989, The Journal of pediatrics.

[5]  M. Cornblath,et al.  Hypoglycemia in Infancy: The Need for a Rational Definition , 1990, Pediatrics.

[6]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[7]  F. Chee,et al.  Expert PID control system for blood glucose control in critically ill patients , 2003, IEEE Transactions on Information Technology in Biomedicine.

[8]  James Stephen Krinsley,et al.  Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. , 2003, Mayo Clinic proceedings.

[9]  G. Putet,et al.  Continuous insulin infusion in hyperglycaemic very-low-birth-weight infants receiving parenteral nutrition. , 2003, Clinical nutrition.

[10]  S. Eaton,et al.  Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. , 2004, Journal of pediatric surgery.

[11]  Christopher E. Hann,et al.  Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model , 2005, Comput. Methods Programs Biomed..

[12]  E. Hey.  Hyperglycaemia and the very preterm baby. , 2005, Seminars in fetal & neonatal medicine.

[13]  D. Dunger,et al.  The continuous glucose monitoring sensor in neonatal intensive care , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[14]  M. Walsh,et al.  Total parenteral nutrition-associated hyperglycemia correlates with prolonged mechanical ventilation and hospital stay in septic infants. , 2006, Journal of pediatric surgery.

[15]  J. Baillargeon,et al.  Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities , 2006, Journal of Perinatology.

[16]  A. Sunehag,et al.  Hyperglycemia Is a Risk Factor for Early Death and Morbidity in Extremely Low Birth-Weight Infants , 2006, Pediatrics.

[17]  K. Heimann,et al.  Are recurrent hyperglycemic episodes and median blood glucose level a prognostic factor for increased morbidity and mortality in premature infants ≤1500 g? , 2007, Journal of perinatal medicine.

[18]  F. Bloomfield,et al.  Survey of the management of neonatal hyperglycaemia in Australasia , 2007, Journal of paediatrics and child health.

[19]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..

[20]  Jessica R Castle,et al.  Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy , 2010, Journal of diabetes science and technology.

[21]  Geoffrey M. Shaw,et al.  Blood Glucose Prediction Using Stochastic Modeling in Neonatal Intensive Care , 2010, IEEE Transactions on Biomedical Engineering.

[22]  J. Stockman.  Early Insulin Therapy in Very-Low-Birth-Weight Infants , 2010 .

[23]  Christopher E. Hann,et al.  Tight glycemic control in critical care - The leading role of insulin sensitivity and patient variability: A review and model-based analysis , 2011, Comput. Methods Programs Biomed..

[24]  Thomas Desaive,et al.  Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control , 2011, Annals of intensive care.

[25]  J. Chase,et al.  Glycemic Levels in Critically Ill Patients: Are Normoglycemia and Low Variability Associated with Improved Outcomes? , 2012, Journal of diabetes science and technology.

[26]  J. Chase,et al.  Pilot study of a model-based approach to blood glucose control in very-low-birthweight neonates , 2012, BMC Pediatrics.

[27]  W. Benitz.  Tight Glycemic Control With Insulin in Hyperglycemic Preterm Babies: A Randomized Controlled Trial , 2012 .

[28]  J. Geoffrey Chase,et al.  STAR Development and Protocol Comparison , 2012, IEEE Transactions on Biomedical Engineering.

[29]  J. Dickson,et al.  On the Problem of Patient-Specific Endogenous Glucose Production in Neonates on Stochastic Targeted Glycemic Control , 2013, Journal of diabetes science and technology.

[30]  J. Geoffrey Chase,et al.  Development and optimisation of stochastic targeted (STAR) glycaemic control for pre-term infants in neonatal intensive care , 2013, Biomed. Signal Process. Control..

[31]  W. Kenneth Ward,et al.  Modeling the Glucose Sensor Error , 2014, IEEE Transactions on Biomedical Engineering.

[32]  J. Chase,et al.  Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial , 2013, The Lancet.

[33]  C. Pretty,et al.  Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial. , 2014, Journal of critical care.

[34]  Jennifer L. Dickson,et al.  A C-Peptide-Based Model of Pancreatic Insulin Secretion in Extremely Preterm Neonates in Intensive Care , 2016, Journal of diabetes science and technology.

[35]  Liam M. Fisk,et al.  Modelling Insulin Clearance and Degradation in Very Premature Infants , 2015 .